How long has zepbound been on the market?

How long has Zepbound been on the market?

Zepbound (tirzepatide) launched in the U.S. in late 2023. It received FDA approval for chronic weight management in November 2023, and pharmacies began selling it soon after that approval.

What date did FDA approve Zepbound, and why does that matter for “on the market”?

“On the market” is usually counted from FDA approval or the first weeks of commercial availability. For Zepbound, FDA approval in November 2023 is the key milestone that marks when it could begin being sold in the U.S.

How long is that as of today?

If you count from FDA approval in November 2023, then Zepbound has been available for roughly about 6–7 months as of June 2024.

Sources

1. DrugPatentWatch.com (Zepbound/tirzepatide drug coverage)